prostratin has been researched along with panobinostat in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohn-Wippert, K; Dar, RD; Megaridis, MR; Tevonian, EN | 1 |
| Andersen, RJ; Brockman, MA; Brumme, ZL; de Silva, ED; Richard, K; Tietjen, I; Williams, DE | 1 |
| McMahon, DK; Mellors, JW; Sluis-Cremer, N; Sobolewski, MD; Zerbato, JM | 1 |
| Covino, DA; Desimio, MG; Doria, M | 1 |
4 other study(ies) available for prostratin and panobinostat
| Article | Year |
|---|---|
Similarity in viral and host promoters couples viral reactivation with host cell migration.
Topics: CD4-Positive T-Lymphocytes; Cell Movement; Depsipeptides; Gene Expression Regulation; HIV Long Terminal Repeat; HIV-1; HL-60 Cells; Host-Pathogen Interactions; Humans; Hydroxamic Acids; Indoles; Ionomycin; Jurkat Cells; Panobinostat; Phorbol Esters; Primary Cell Culture; Promoter Regions, Genetic; Receptors, CXCR4; Tamoxifen; tat Gene Products, Human Immunodeficiency Virus; Transcription, Genetic; Tumor Necrosis Factor-alpha; Virus Activation; Virus Latency; Vorinostat | 2017 |
Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products.
Topics: Anti-HIV Agents; Aquatic Organisms; Biological Products; CD4-Positive T-Lymphocytes; Cell Line; Cell Survival; Disulfides; Drug Discovery; High-Throughput Screening Assays; HIV Infections; HIV-1; Humans; Panobinostat; Phorbol Esters; Proviruses; Tyrosine; Virus Activation; Virus Latency | 2018 |
Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1.
Topics: Adult; CD28 Antigens; CD4-Positive T-Lymphocytes; Depsipeptides; Female; Flow Cytometry; HIV-1; Humans; Interleukin-2; Male; Middle Aged; Panobinostat; Phorbol Esters; Phytohemagglutinins | 2019 |
Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir.
Topics: CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Interleukin-15; Killer Cells, Natural; Panobinostat; Virus Activation; Virus Latency | 2022 |